Renaissance Technologies LLC Acquires New Holdings in Adlai Nortye Ltd. Sponsored ADR $ANL

Renaissance Technologies LLC bought a new position in Adlai Nortye Ltd. Sponsored ADR (NASDAQ:ANL) in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund bought 66,000 shares of the company’s stock, valued at approximately $457,000.

Separately, SmartHarvest Portfolios LLC grew its holdings in Adlai Nortye by 8.5% during the first quarter. SmartHarvest Portfolios LLC now owns 16,367 shares of the company’s stock valued at $113,000 after purchasing an additional 1,279 shares during the last quarter. 35.21% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of equities analysts have recently commented on ANL shares. Weiss Ratings reissued a “sell (e+)” rating on shares of Adlai Nortye in a research report on Tuesday, July 14th. HC Wainwright upped their price objective on shares of Adlai Nortye from $16.00 to $20.00 and gave the stock a “buy” rating in a report on Monday, April 20th. Oppenheimer started coverage on shares of Adlai Nortye in a research note on Thursday, May 28th. They issued an “outperform” rating and a $32.00 target price on the stock. Cantor Fitzgerald initiated coverage on shares of Adlai Nortye in a report on Monday, June 22nd. They issued an “overweight” rating on the stock. Finally, JonesTrading assumed coverage on shares of Adlai Nortye in a research report on Thursday, May 14th. They set a “buy” rating and a $22.00 target price for the company. Five analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $24.25.

Adlai Nortye Stock Up 0.7%

ANL opened at $13.34 on Tuesday. The stock’s 50 day moving average price is $11.50 and its two-hundred day moving average price is $10.88. Adlai Nortye Ltd. Sponsored ADR has a 12-month low of $0.88 and a 12-month high of $17.25.

Adlai Nortye Company Profile

Adlai Nortye Inc (NASDAQ: ANL) is a specialty chemical manufacturer headquartered in China’s Jiangsu Province. The company focuses on the research, development, production and sale of fine chemicals, with a primary emphasis on amino acids and their derivatives.

Adlai Nortye’s product portfolio includes betaine compounds, a range of high-purity L-amino acids such as L-methionine, L-threonine and glycine, as well as various chemical intermediates. These offerings serve multiple end markets, including animal feed and nutrition, personal care and cosmetic formulations, pharmaceutical ingredients and industrial chemical processes.

The company operates multiple production facilities alongside an in-house research and development center dedicated to process innovation and quality control.